Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27870207 | 0.80 | LMNA (0.43) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL28168488 | 0.73 | USP2 (0.37) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL28259629 | 0.70 | USP2 (0.35) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL1170713 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL28778146 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL23705188 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL1111426 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL2635057 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL3172348 | 0.70 | LMNA (0.40) | USP2SLCO1B1PDE4ALMNAL3MBTL1 | |
| SCHEMBL6231892 | 0.69 | LMNA (0.36) | USP2SLCO1B1PDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6884842-B2 | Molecular compounds having complementary surfaces to targets | ALNIS BIOSCIENCES, INC. (US) | 2005-04-26 | — | — | US | claimed |
| US-20070275046-A1 | Noval Surfactants and Applications Thereof | TS PHARMA (FR) | 2007-11-29 | — | — | US | disclosed |
| EP-1708993-A2 | NOVEL SURFACTANTS AND APPLICATIONS THEREOF | TS Pharma (FR) | 2006-10-11 | — | — | EP | disclosed |
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | ALNIS BIOSCIENCES, INC. | 2005-06-16 | — | — | US | disclosed |
| EP-1531868-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | Alnis Biosciences, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2005040105-A2 | NOVEL SURFACTANTS AND APPLICATIONS THEREOF | TS PHARMA (FR) | 2005-05-06 | — | — | WO | disclosed |
| WO-2005027873-A2 | THERAPEUTIC AMINOGLYCOSIDE-CONTAINING HYDROGEL NANOPARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | ALNIS BIOSCIENCES INC. | 2004-07-01 | — | — | US | disclosed |
| US-20040058006-A1 | High affinity nanoparticles | ALNIS BIOSCIENCES, INC. | 2004-03-25 | — | — | US | disclosed |
| WO-2003101425-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| EP-1276507-A2 | HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES | Alnis Biosciences, Inc. (US) | 2003-01-22 | — | — | EP | disclosed |
| WO-2001078786-A2 | HIGH AFFINITY PEPTIDE-CONTAINING NANOPARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2001-10-25 | — | — | WO | disclosed |
| US-6217901-B1 | POLYMERIZING POLYMER AND LIPOSOMES | ALNIS, LLC | 2001-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | CD44, EPCAM, CLTB | USP2 2442/4885SLCO1B1 1266/4885PDE4A 3549/4885 |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | LNPEP, IAPP, ACP1 | USP2 1071/4885SLCO1B1 3671/4885PDE4A 4437/4885 |
| US-20070275046-A1 | Noval Surfactants and Applications Thereof | SGMS1, SGMS2, ANXA6 | USP2 2445/4885SLCO1B1 1170/4885PDE4A 4187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.